Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall Aesculap Arcadius Trial Insertion Instrument (ME020R/ME020RUS)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
  Class 2 Device Recall Aesculap Arcadius Trial Insertion Instrument (ME020R/ME020RUS) see related information
Date Initiated by Firm September 20, 2013
Date Posted November 19, 2013
Recall Status1 Terminated 3 on December 16, 2014
Recall Number Z-0361-2014
Recall Event ID 66534
Product Classification Orthopedic manual surgical instrument - Product Code LXH
Product Aesculap Arcadius XP L Trial Insertion Instrument (ME020R/ME020R-US)
Code Information model no. ME020R
Recalling Firm/
Manufacturer		 Aesculap, Inc.
3773 Corporate Pkwy
Center Valley PA 18034-8217
For Additional Information Contact Customer Support
800-258-1946 Ext. 5067
Manufacturer Reason
for Recall		 The trial insertion instrument may disassemble during use due to a potentially weak weld on then trial inserter shaft block area located near the thumb wheel.
FDA Determined
Cause 2		 Device Design
Action An Important Product Removal Notification dated September 20, 2013 was sent to customers.
Quantity in Commerce 30
Distribution Worldwide distribution: USA (nationwide) GA, TN, CA, WY, NV, TX, OK, OH, and IL; and internationally to Canada.
Total Product Life Cycle TPLC Device Report
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
-
-